Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

NCT ID: NCT04111263 Phase: NA Status: COMPLETED Enrollment: 33 Completion: 2022-11-05

Conditions

Gastrointestinal Injury, Acute Mountain Sickness

Interventions

FP, Placebo, High altitude, Sea level

Summary

The aim of this randomized, crossover clinical trial is to determine the efficacy of a gut microbiota-targeted nutritional intervention containing a blend of fermentable fibers and polyphenols (FP) for mitigating increases in GI permeability, and decrements in immune function and neuropsychologic performance following rapid ascent to simulated high altitude. Fifteen healthy young adults will participate in each of three study phases that include a 14-day supplementation period in which participants will consume 1 of 2 supplement bars: placebo (PL, will be consumed during 2 phases) and FP supplementation (will be consumed during one phase only). During the final 2-d of each phase, participants will live in a hypobaric chamber under sea level or high altitude conditions.

Primary Outcome

Difference in intestinal permeability

Source

ClinicalTrials.gov